TNF/TNFR1 signaling mediates doxorubicin-induced diaphragm weakness

Doxorubicin acts through tumor necrosis factor receptor subtype 1 to cause dysfunction of murine skeletal muscle

(2009) Laura A. A. Gilliam et al.   JOURNAL OF APPLIED PHYSIOLOGY

CCAAT/enhancer binding proteins α and β regulate the tumor necrosis factor receptor 1 gene promoter

(2009) Jillian A. Bristol et al.   MOLECULAR IMMUNOLOGY

Effects of genetic and pharmacological inhibition of TNF-α in the regulation of inflammation in macrophages

(2009) Concetta Crisafulli et al.   PHARMACOLOGICAL RESEARCH

Tumor necrosis factor alpha drugs in rheumatoid arthritis: systematic review and metaanalysis of efficacy and safety

(2008) Alberto Alonso-Ruiz et al.   BMC MUSCULOSKELETAL DISORDERS

Effect of tumour necrosis factor- receptor 1 genetic deletion on carrageenan-induced acute inflammation: a comparison with etanercept

(2008) E. Mazzon et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

TNF-α acts via TNFR1 and muscle-derived oxidants to depress myofibrillar force in murine skeletal muscle

(2008) Brian J. Hardin et al.   JOURNAL OF APPLIED PHYSIOLOGY

Evidence-Based Recommendations for Cancer Fatigue, Anorexia, Depression, and Dyspnea

(2008) Sydney M. Dy et al.   JOURNAL OF CLINICAL ONCOLOGY

Induction of MuRF1 Is Essential for TNF-α-Induced Loss of Muscle Function in Mice

(2008) Volker Adams et al.   JOURNAL OF MOLECULAR BIOLOGY

Inhibition of peripheral TNF can block the malaise associated with CNS inflammatory diseases

(2008) Y. Jiang et al.   NEUROBIOLOGY OF DISEASE

Circulating TNFR1 exosome-like vesicles partition with the LDL fraction of human plasma

(2007) Jing Zhang et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Mechanisms of exertional dyspnea in patients with cancer

(2007) J. Travers et al.   JOURNAL OF APPLIED PHYSIOLOGY